STANGELAND APOTEK AS

4316 SANDNES

Finances

Share Ownership

Return on Equity

−1,62 %

Current Ratio

1,24

Debt-to-Equity Ratio

1,13

Key figures (NOK)	2022	2021	2020	2019
Revenue	15 853 000	17 028 000	13 897 000	7 974 000
Net Income	−8 000	532 000	811 000	−355 000
Total Assets	3 556 000	3 792 000	4 015 000	2 467 000
Total Equity	495 000	991 000	859 000	48 000

Income (NOK)	2022	2021	2020	2019
Revenue	15 853 000	17 028 000	13 897 000	7 974 000
Expenditure	15 838 000	16 340 000	13 046 000	8 278 000
Operating Profit	14 000	689 000	851 000	−304 000
Financial Income	5 000	2 000	2 000	2 000
Financial Costs	29 000	28 000	42 000	53 000
Financial Balance	−24 000	−26 000	−40 000	−51 000
Earnings Before Tax	−9 000	662 000	811 000	−355 000
Tax	−1 000	130 000	0	0
Net Income	−8 000	532 000	811 000	−355 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	443 000	550 000	637 000	796 000
Total Current Assets	3 113 000	3 242 000	3 378 000	1 672 000
Total Assets	3 556 000	3 792 000	4 015 000	2 467 000
Total Retained Equity	452 000	461 000	−71 000	−882 000
Total Equity	495 000	991 000	859 000	48 000
Total Long-Term Debt	560 000	763 000	950 000	1 150 000
Total Current Debt	2 501 000	2 039 000	2 206 000	1 269 000
Total Equity and Debt	3 556 000	3 792 000	4 015 000	2 467 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	15 853 000	17 028 000	13 897 000	7 974 000
Other Income	0	0	0	0
Revenue	15 853 000	17 028 000	13 897 000	7 974 000
Cost of Goods Sold	12 721 000	13 664 000	10 707 000	5 944 000
Salary Costs	2 292 000	1 937 000	1 750 000	1 694 000
Depreciation	107 000	134 000	159 000	199 000
Impairment	0	0	0	0
Expenditure	15 838 000	16 340 000	13 046 000	8 278 000
Operating Profit	14 000	689 000	851 000	−304 000
Financial Income	5 000	2 000	2 000	2 000
Financial Costs	29 000	28 000	42 000	53 000
Financial Balance	−24 000	−26 000	−40 000	−51 000
Dividends	0	0	0	0
Net Income	−8 000	532 000	811 000	−355 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	428 000	535 000	637 000	796 000
Total Tangible Assets	428 000	535 000	637 000	796 000
Total Fiancial Fixed Assets	15 000	15 000	0	0
Total Fixed Assets	443 000	550 000	637 000	796 000
Stock	1 241 000	1 304 000	1 231 000	916 000
Total Investments	0	0	0	0
Cash, Bank	1 120 000	1 451 000	1 070 000	523 000
Total Current Assets	3 113 000	3 242 000	3 378 000	1 672 000
Total Assets	3 556 000	3 792 000	4 015 000	2 467 000
Total Equity	495 000	991 000	859 000	48 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	560 000	763 000	950 000	1 150 000
Creditors	2 016 000	1 466 000	1 803 000	934 000
Unpaid Taxes	301 000	339 000	265 000	199 000
Dividends	0	0	0	0
Other Current Debt	182 000	117 000	138 000	137 000
Total Current Debt	2 501 000	2 039 000	2 206 000	1 269 000
Total Equity and Debt	3 556 000	3 792 000	4 015 000	2 467 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−1,62 %	53,68 %	94,41 %	−739,58 %
Debt-to-Equity Ratio	1,13	0,77	1,11	23,96
Operating Profit Margin	0,09 %	4,05 %	6,12 %	−3,81 %
Current Ratio	1,24	1,59	1,53	1,32
Quick Ratio	2,47	4,41	3,46	4,74
Equity Ratio	0,14	0,26	0,21	0,02
Gross Profit Margin	19,76 %	19,76 %	22,95 %	25,46 %